FindTrial
Sign In

Effect of Curcuminoids on Myocardial Necrosis After Percutaneous Coronary Intervention

Effect of Curcuminoids on Myocardial Necrosis After Percutaneous Coronary Intervention : Prospective randomized double-blind placebo control trial.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160715002
Enrollment
Unknown
Registered
2016-07-15
Start date
2013-05-30
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All consecutive patients (age≥18 years) undergoing Percutaneous Coronary Intervention. Curcuminoids Myocardial Necrosis Myocardial Infarction Percutaneous Coronary Intervention

Interventions

Curcuminoids reduce MI in patient after PCI&#44
Randomized double&#45
blind placebo control. ,Placebo comparator
Experimental Drug,Placebo Comparator No treatment
Curcuminoids,Placebo

Sponsors

Faculty of Medicine, Chiang Mai University
Lead Sponsor
The Thai Traditional Medical Knowledge Fund
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 0 Years

Inclusion criteria

Inclusion criteria: Patient who had Coronary artery disease which undergoing Percutaneous Coronary Intervention.

Exclusion criteria

Exclusion criteria: Patient who had Cholestatic jaundice or Hepatitis.

Design outcomes

Primary

MeasureTime frame
Myocardial infarction 2 years Outcome using hs-cTnT level, CRP level, MDA level and ECG—

Secondary

MeasureTime frame
C-reactive protein level After PCI Laboratory report,Malondialdehyde level 2 years Laboratory report—

Countries

Thailand

Contacts

Public ContactWanwarang Wongcharoen

Faculty of Medicine, Chiang Mai University

bwanwarang@yahoo.com+66 5393 6716

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026